Latest News and Press Releases

Eledon Pharmaceuticals to Present Results from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at Kidney Week

ROCKVILLE, Md., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Today, the American Kidney Fund (AKF) is proud to announce that they are a collaborator of the American Heart Association’s...

ROCKVILLE, Md., Sept. 12, 2025 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF)'s sixth annual national summit on Unknown Causes of Kidney Disease (UCKD) will focus in part on rural and community...

ROCKVILLE, Md., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Today, the American Kidney Fund (AKF) and the IgA Nephropathy Foundation, joined by more than 50 advocates living with rare kidney diseases, are...

Eledon Pharmaceuticals to Participate in Cantor Global Healthcare Conference 2025

ROCKVILLE, Md., Aug. 27, 2025 (GLOBE NEWSWIRE) -- While most Americans believe they have basic knowledge of kidney disease, there are substantial gaps in understanding how it can be prevented,...

ROCKVILLE, Md., Aug. 20, 2025 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) is proud to announce the launch of its first-ever podcast, "The Kidney Collective™." Introduced as a seven-episode,...

Eledon Pharmaceuticals Reports Second Quarter 2025 Operating and Financial Results

ROCKVILLE, Md., Aug. 12, 2025 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) today announced new resources to empower people living with and at risk for kidney disease, as well as health care...

Eledon Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation